{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:25:43Z","timestamp":1792513543745,"version":"4.5.0"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00813","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T05:12:13Z","timestamp":1555391533000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Nucleoside Hydrolase NH 36: A Vital Enzyme for the Leishmania Genus in the Development of T-Cell Epitope Cross-Protective Vaccines"],"prefix":"10.3389","volume":"10","author":[{"given":"Clarisa Beatriz","family":"Palatnik-de-Sousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"9375","DOI":"10.1073\/pnas.0703678104","article-title":"Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy","volume":"104","author":"Lukes","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ijpara.2006.03.006","article-title":"Towards multilocus sequence typing of the Leishmania donovani complex: resolving genotypes and haplotypes for five polymorphic metabolic enzymes (ASAT, GPI, NH1, NH2, PGD)","volume":"36","author":"Mauricio","year":"2006","journal-title":"Int J Parasitol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.bbapap.2009.02.011","article-title":"Crystal structures of T. vivax nucleoside hydrolase in complex with new potent and specific inhibitors","volume":"1794","author":"Vers\u00e9es","year":"2009","journal-title":"Biochim Biophys Acta."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1021\/bi702448s","article-title":"Structural basis for substrate specificity in group I nucleoside hydrolases","volume":"47","author":"Iovane","year":"2008","journal-title":"Biochemistry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0124183","DOI":"10.1371\/journal.pone.0124183","article-title":"Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis multiplication In Vitro","volume":"10","author":"Freitas","year":"2015","journal-title":"PLoS ONE."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0004297","DOI":"10.1371\/journal.pntd.0004297","article-title":"Immucillins ImmA and ImmH are effective and non-toxic in the treatment of experimental visceral leishmaniasis","volume":"9","author":"Freitas","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cbi.2016.12.004","article-title":"The importance of nucleoside hydrolase enzyme (NH) in studies to treatment of Leishmania: a review","volume":"263","author":"Figueroa-Villar","year":"2017","journal-title":"Chem Biol Interact."},{"key":"B8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jtbi.2017.03.010","article-title":"Combined virtual screening, MMPBSA, molecular docking and dynamics studies against deadly anthrax: an in silico effort to inhibit Bacillus anthracis nucleoside hydrolase","volume":"420","author":"Karami","year":"2017","journal-title":"J Theor Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e866","DOI":"10.1371\/journal.pntd.0000866","article-title":"Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response","volume":"4","author":"Nico","year":"2010","journal-title":"PLoS Negl Trop Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fimmu.2014.00189","article-title":"Cross-protective immunity to Leishmania amazonensis is mediated by CD4+ and CD8+ epitopes of Leishmania donovani nucleoside hydrolase terminal domains","volume":"5","author":"Nico","year":"2014","journal-title":"Front Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fimmu.2014.00273","article-title":"Leishmania donovani nucleoside hydrolase terminal domains in cross-protective immunotherapy against Leishmania amazonensis murine infection","volume":"5","author":"Nico","year":"2014","journal-title":"Front Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fimmu.2017.00100","article-title":"A chimera containing CD4+ and CD8+ T-cell epitopes of the Leishmania donovani nucleoside hydrolase (NH36) optimizes cross-protection against Leishmania amazonesis Infection","volume":"8","author":"Alves-Silva","year":"2017","journal-title":"Front Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fimmu.2017.00227","article-title":"Leishmania donovani nucleoside hydrolase (NH36) domains induce T-cell cytokine responses in human visceral leishmaniasis","volume":"8","author":"Barbosa Santos","year":"2017","journal-title":"Front Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3389\/fimmu.2017.00750","article-title":"F1 domain of the Leishmania (Leishmania) donovani nucleoside hydrolase promotes a Th1 response in Leishmania (Leishmania) infantum cured patients and in asymptomatic individuals living in an endemic area of leishmaniasis","volume":"8","author":"Carrillo","year":"2017","journal-title":"Front Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1038\/cti.2015.6","article-title":"From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE.","volume":"4","author":"Coler","year":"2015","journal-title":"Clin Transl Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1128\/JB.185.11.3373-3378.2003","article-title":"Genes of Bacillus cereus and Bacillus anthracis encoding proteins of the exosporium","volume":"185","author":"Todd","year":"2003","journal-title":"J Bacteriol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1016\/j.vaccine.2008.07.029","article-title":"Immunogenicity assay of the Leishmune vaccine against canine visceral leishmaniasis in Brazil","volume":"26","author":"Borja-Cabrera","year":"2008","journal-title":"Vaccine."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/j.vaccine.2006.11.057","article-title":"Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil","volume":"25","author":"Parra","year":"2007","journal-title":"Vaccine."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1016\/j.vaccine.2005.05.011","article-title":"Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs","volume":"23","author":"Nogueira","year":"2005","journal-title":"Vaccine."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.vaccine.2005.11.061","article-title":"The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine","volume":"24","author":"Saraiva","year":"2006","journal-title":"Vaccine."},{"key":"B21","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1586\/14760584.7.6.833","article-title":"FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine","volume":"7","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Exp Rev Vaccines."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1016\/j.vaccine.2009.03.045","article-title":"Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas","volume":"27","author":"Palatnik-de-Sousa","year":"2009","journal-title":"Vaccine."},{"key":"B23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0166-6851(02)00010-5","article-title":"Nucleoside hydrolase from Leishmania (L.) donovani is an antigen diagnostic for visceral leishmaniasis","volume":"120","author":"Santana","year":"2002","journal-title":"Mol Biochem Parasitol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1128\/IAI.73.2.812-819.2005","article-title":"Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis","volume":"73","author":"Aguilar-Be","year":"2005","journal-title":"Infect Immun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0201432","DOI":"10.1371\/journal.pone.0201432","article-title":"Study of purinosome assembly in cell-based model systems with de novo purine synthesis and salvage pathway deficiencies","volume":"13","author":"Baresova","year":"2018","journal-title":"PLoS ONE."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e26916","DOI":"10.1371\/journal.pone.0026916","article-title":"Plasmodium falciparum parasites are killed by a transition state analogue of purine nucleoside phosphorylase in a primate animal model","volume":"6","author":"Cassera","year":"2011","journal-title":"PLoS ONE."},{"key":"B27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0166-6851(82)90035-4","article-title":"Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum","volume":"5","author":"Reyes","year":"1982","journal-title":"Mol Biochem Parasitol."},{"key":"B28","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2307\/3281440","article-title":"Purine salvage in Entamoeba histolytica","volume":"71","author":"Lo","year":"1985","journal-title":"J Parasitol."},{"key":"B29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0166-6851(86)90061-7","article-title":"Purine-metabolising enzymes in Entamoeba histolytica","volume":"19","author":"Hassan","year":"1986","journal-title":"Mol Biochem Parasitol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"39973","DOI":"10.1074\/jbc.M205595200","article-title":"The adenine phosphoribosyltransferase from Giardia lamblia has a unique reaction mechanism and unusual substrate binding properties","volume":"277","author":"Sarver","year":"2002","journal-title":"J Biol Chem."},{"key":"B31","doi-asserted-by":"crossref","first-page":"10601","DOI":"10.1016\/S0021-9258(18)81663-5","article-title":"Purine metabolism in Toxoplasma gondii","volume":"264","author":"Krug","year":"1989","journal-title":"J Biol Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1128\/EC.00308-13","article-title":"Inhibition and structure of Toxoplasma gondii purine nucleosyde phophorylase","volume":"13","author":"Donaldson","year":"2014","journal-title":"Eukaryot Cell."},{"key":"B33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1021\/acsinfecdis.7b00172","article-title":"Immucillins in infectious diseases","volume":"4","author":"Evans","year":"2018","journal-title":"Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1016\/j.bbagen.2018.08.015","article-title":"Cloning and characterisation of the equilibrative nucleoside transporter family of Trypanosoma cruzi: ultra-high affinity and selectivity to survive in the intracellular niche","volume":"1862","author":"Campagnaro","year":"2018","journal-title":"Biochim Biophys Acta Gen Subj."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0006301","DOI":"10.1371\/journal.pntd.0006301","article-title":"Evaluation of the Trypanosoma brucei 6-oxopurine salvage pathway as a potential target for drug discovery","volume":"12","author":"Dole\u017delov\u00e1","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"key":"B36","doi-asserted-by":"crossref","first-page":"21713","DOI":"10.1074\/jbc.271.36.21713","article-title":"Purine-specific nucleoside N-ribohydrolase from Trypanosoma brucei brucei. Purification, specificity, and kinetic mechanism","volume":"271","author":"Parkin","year":"1996","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1107\/S0907444913010792","article-title":"Structures of purine nucleosidase from Trypanosoma brucei bound to isozyme-specific trypanocidals and a novel metalorganic inhibitor","volume":"69","author":"Giannese","year":"2013","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"B38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0304-4165(78)90104-6","article-title":"Purine metabolism in Leishmania donovani and Leishmania braziliensis","volume":"544","author":"Marr","year":"1978","journal-title":"Biochem Biophys Acta"},{"key":"B39","doi-asserted-by":"crossref","first-page":"21114","DOI":"10.1074\/jbc.274.30.21114","article-title":"Nucleoside hydrolase from Leishmania major. Cloning, expression, catalytic properties, transition state inhibitors, and the 2.5-\u00e5 crystal structure","volume":"274","author":"Shi","year":"1999","journal-title":"J Biol Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exppara.2017.06.001","article-title":"3'nucleotidase\/nuclease in protozoan parasites: molecular and biochemical properties and physiological roles","volume":"179","author":"Freitas-Mesquita","year":"2017","journal-title":"Exp Parasitol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.molbiopara.2006.09.002","article-title":"Functional characterization of nucleoside transporter gene replacements in Leishmania donovani","volume":"150","author":"Liu","year":"2006","journal-title":"Mol Biochem Parasitol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-0-387-77570-8_12","article-title":"Purine and pyrimidine metabolism in Leishmania","volume":"625","author":"Carter","year":"2008","journal-title":"Adv Exp Med Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0378-1119(01)00768-5","article-title":"A nonspecific nucleoside hydrolase from Leishmania donovani: implications for purine salvage by the parasite","volume":"280","author":"Cui","year":"2001","journal-title":"Gene."},{"key":"B44","unstructured":"National Institute of Health (NIH)2014"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1021\/jm801421q","article-title":"Third-generation immucillins: syntheses and bioactivities of acyclic immucillin inhibitors of human purine nucleoside phosphorylase","volume":"52","author":"Clinch","year":"2009","journal-title":"J Med Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e1003938","DOI":"10.1371\/journal.ppat.1003938","article-title":"Metabolic reprogramming during purine stress in the protozoan pathogen Leishmania donovani","volume":"10","author":"Martin","year":"2014","journal-title":"PLoS Pathog."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE."},{"key":"B48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1756-3305-4-197","article-title":"One Health: the global challenge of epidemic and endemic leishmaniasis","volume":"4","author":"Palatnik-de-Sousa","year":"2011","journal-title":"Parasit Vectors."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.vaccine.2016.03.019","article-title":"Field randomized trial to evaluate the efficacy of the Leish-Tec\u00ae vaccine against canine visceral leishmaniasis in an endemic area of Brazil","volume":"34","author":"Regina-Silva","year":"2016","journal-title":"Vaccine."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e3213","DOI":"10.1371\/journal.pntd.0003213","article-title":"A randomised, double-blind, controlled efficacy trial of the LiESP\/QA-21 vaccine in na\u00efve dogs exposed to two Leishmania infantum transmission seasons","volume":"8","author":"Oliva","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"5964","DOI":"10.1016\/j.vaccine.2009.07.069","article-title":"The chimerical multi-component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection","volume":"27","author":"Carcel\u00e9n","year":"2009","journal-title":"Vaccine."},{"key":"B52","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.57.3.754-763.1989","article-title":"Inhibition of Leishmania donovani promastigote internalization into murine macrophages by chemically defined parasite glycoconjugate ligands","volume":"57","author":"Palatnik","year":"1989","journal-title":"Infect Immun."},{"key":"B53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0001-706X(93)90006-W","article-title":"Leishmania donovani surface glycoconjugate GP36 is the major immunogen component of the fucose-mannose ligand (FML)","volume":"53","author":"Palatnik-de-Sousa","year":"1993","journal-title":"Acta Trop."},{"key":"B54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00928181","article-title":"A new approach to the phylogeny of Leishmania: species specificity of glycoconjugate ligands for promastigote internalization into murine macrophages","volume":"76","author":"Palatnik","year":"1990","journal-title":"Parasitol Res."},{"key":"B55","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0035-9203(95)90022-5","article-title":"Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis","volume":"89","author":"Palatnik-de-Sousa","year":"1995","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"B56","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1999.61.296","article-title":"The fucose-mannose ligand-ELISA in the diagnosis and prognosis of canine visceral leishmaniasis in Brazil","volume":"61","author":"Cabrera","year":"1999","journal-title":"Am J Trop Med Hyg."},{"key":"B57","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4269\/ajtmh.1997.57.168","article-title":"Prevalence of anti-Leishmania donovani antibody among Brazilian blood donors and multiply transfused hemodialysis patients","volume":"57","author":"Luz","year":"1997","journal-title":"Am J Trop Med Hyg."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1016\/S0264-410X(01)00031-7","article-title":"Vaccination of Balb\/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani","volume":"19","author":"Paraguai de Souza","year":"2001","journal-title":"Vaccine."},{"key":"B59","first-page":"547","article-title":"Experimental murine Leishmania donovani infection: immunoprotection by the fucose-mannose ligand (FML)","volume":"27","author":"Palatnik-de-Sousa","year":"1994","journal-title":"Braz J Med Biol Res."},{"key":"B60","first-page":"290","article-title":"Vaccination with the FML antigen (Fucose Mannose Ligand) of Leishmania donovani protects hamsters from experimental Viceral Leishmaniasis","volume":"46","author":"Palatnik de Sousa","year":"1994","journal-title":"J Braz Soc Adv Sci Ci\u00eancia e Cultura"},{"key":"B61","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0264-410X(02)00444-9","article-title":"Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis","volume":"21","author":"Santos","year":"2002","journal-title":"Vaccine."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1016\/j.vaccine.2006.02.034","article-title":"Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis","volume":"24","author":"Oliveira-Freitas","year":"2006","journal-title":"Vaccine."},{"key":"B63","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (S\u00e3o Gon\u00e7alo do Amaranto, RN)","volume":"19","author":"da Silva","year":"2000","journal-title":"Vaccine."},{"key":"B64","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S\u00e3o Gon\u00e7alo do Amarante, RN)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine."},{"key":"B65","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/S0264-410X(03)00046-X","article-title":"IgG1\/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis","volume":"21","author":"de Oliveira Mendes","year":"2003","journal-title":"Vaccine."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1016\/j.vaccine.2003.11.039","article-title":"Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine","volume":"22","author":"Borja-Cabrera","year":"2004","journal-title":"Vaccine."},{"key":"B67","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1016\/j.vaccine.2007.06.005","article-title":"Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune vaccine","volume":"25","author":"Santos","year":"2007","journal-title":"Vaccine."},{"key":"B68","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.vaccine.2009.09.071","article-title":"Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis","volume":"28","author":"Borja-Cabrera","year":"2010","journal-title":"Vaccine."},{"key":"B69","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s13071-016-1752-6","article-title":"Multicomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec\u00ae and Leishmune\u00ae vaccines against visceral leishmaniasis","volume":"9","author":"de","year":"2016","journal-title":"Parasit Vectors."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.vaccine.2013.12.046","article-title":"Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis","volume":"32","author":"Fernandes","year":"2014","journal-title":"Vaccine."},{"key":"B71","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.vetpar.2016.02.009","article-title":"Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxideproduction and expression of cell activation\/migration molecules in neutrophils and monocytes","volume":"220","author":"Moreira","year":"2016","journal-title":"Vet Parasitol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12917-015-0397-6","article-title":"One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis","volume":"11","author":"Costa-Pereira","year":"2015","journal-title":"BMC Vet Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.vetimm.2009.12.008","article-title":"Diminished CD4+\/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis","volume":"135","author":"de Lima","year":"2010","journal-title":"Vet Immunol Immunopathol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.vaccine.2008.11.104","article-title":"T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune","volume":"27","author":"Ara\u00fajo","year":"2009","journal-title":"Vaccine."},{"key":"B75","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S1359-6446(03)02864-2","article-title":"Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity","volume":"8","author":"Marciani","year":"2003","journal-title":"Drug Discov Today."},{"key":"B76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.1996.55.125","article-title":"The logic of visceral leishmaniasis control","volume":"55","author":"Dye","year":"1996","journal-title":"Am J Trop Med Hyg."},{"key":"B77","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1590\/S0037-86821996000200008","article-title":"The FML (Fucose Mannose Ligand) of Leishmania donovani. a new tool in diagnosis, prognosis, transfusional control and vaccination against human kala-azar","volume":"29","author":"Palatnik de Sousa","year":"1996","journal-title":"Rev Soc Bras Med Trop."},{"key":"B78","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect Immun."},{"key":"B79","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/S0264-410X(01)00023-8","article-title":"Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response","volume":"19","author":"Ghosh","year":"2001","journal-title":"Vaccine."},{"key":"B80","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0264-410X(01)00322-X","article-title":"Immunization with A2 protein results in a mixed Th1\/Th2 and a humoral response which protects mice against Leishmania donovani infections","volume":"20","author":"Ghosh","year":"2001","journal-title":"Vaccine."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e2853","DOI":"10.1371\/journal.pntd.0002853","article-title":"Clinical and parasitological protection in a Leishmania infantum \u2013 macaque model vaccinated with adenovirus and the recombinant A2 antigen","volume":"8","author":"Grimaldi","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"B82","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1016\/j.vaccine.2008.05.095","article-title":"Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein","volume":"26","author":"Fernandes","year":"2008","journal-title":"Vaccine."},{"key":"B83","doi-asserted-by":"publisher","first-page":"e0185438","DOI":"10.1371\/journal.pone.0185438","article-title":"Field trial of efficacy of the Leish-tec\u00ae vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates","volume":"12","author":"Grimaldi","year":"2017","journal-title":"PLoS ONE."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.vaccine.2018.02.111","article-title":"A large-scale field randomized trial demonstrates safety and efficacy of the vaccine LetiFend\u00ae against canine leishmaniosis","volume":"36","author":"Fern\u00e1ndez Cotrina","year":"2018","journal-title":"Vaccine."},{"key":"B85","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.vetpar.2015.01.003","article-title":"Canine Leishmania vaccines: still a long way to go","volume":"208","author":"Gradoni","year":"2015","journal-title":"Vet Parasitol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13071-016-1412-x","article-title":"Regulation of immunity during visceral Leishmania infection","volume":"9","author":"Rodrigues","year":"2016","journal-title":"Parasit Vectors."},{"key":"B87","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1128\/CVI.00251-16","article-title":"Optimizing immunization strategies for the induction of antigen specific CD4 and CD8 T cell responses for protection against intracellular parasites","volume":"23","author":"Hofmeyer","year":"2016","journal-title":"Clin Vaccine Immunol."},{"key":"B88","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1146\/annurev.iy.07.040189.003021","article-title":"T-cell responses and immunity to experimental infection with Leishmania major","volume":"7","author":"Muller","year":"1989","journal-title":"Annu Rev Immunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protec-tion against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e1874","DOI":"10.1371\/journal.pntd.0001874","article-title":"Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis","volume":"6","author":"Singh","year":"2012","journal-title":"PLoS Negl Trop Dis."},{"key":"B91","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fimmu.2012.00251","article-title":"Immunobiology of visceral leishmaniasis","volume":"3","author":"Kumar","year":"2012","journal-title":"Front Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1128\/IAI.74.1.773-776.2006","article-title":"Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen","volume":"74","author":"Polley","year":"2006","journal-title":"Infect Immun."},{"key":"B93","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fmicb.2016.00467","article-title":"Post-genomics and vaccine improvement for Leishmania","volume":"7","author":"Seyed","year":"2016","journal-title":"Front Microbiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pep.2016.10.008","article-title":"Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasis","volume":"130","author":"McAtee","year":"2017","journal-title":"Protein Expr Purif."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","article-title":"Status of vaccine research and development of vaccines for leishmaniasis","volume":"34","author":"Gillespie","year":"2016","journal-title":"Vaccine."},{"key":"B96","volume-title":"Imunobiologia de Janeway","author":"Murphy","year":"2014"},{"key":"B97","doi-asserted-by":"publisher","first-page":"5974574","DOI":"10.1155\/2017\/5974574","article-title":"The Immune epitope database: how data are entered and retrieved","volume":"2017","author":"Fleri","year":"2017","journal-title":"J Immunol Res."},{"key":"B98","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.provac.2009.07.022","article-title":"The Nucleoside hydrolase DNA vaccine VR1012NH36 in prophylactic vaccination against mice tegumentar leishmaniaisis","volume":"1","author":"Souza","year":"2009","journal-title":"Proc Vaccinol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1016\/j.vaccine.2006.03.005","article-title":"Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of","volume":"24","author":"Gamboa-Le\u00f3n","year":"2006","journal-title":"L. donovani. Vaccine."},{"key":"B100","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.provac.2009.07.019","article-title":"Nucleoside hydrolase DNA vaccine against canine visceral leishmaniasis","volume":"1","author":"Borja-Cabrera","year":"2009","journal-title":"Proc Vaccinol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.provac","article-title":"The leishmune\u00ae's nucleoside hydrolase DNA vaccine as an aid in immunotherapy of canine visceral leishmaniasis","volume":"6","author":"Borja-Cabrera","year":"2012","journal-title":"Proc Vaccinol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.biori.2017.10.001","article-title":"The development of veterinary vaccines: a review of traditional methods and modern biotechnology approaches","volume":"1","author":"Jorge","year":"2017","journal-title":"Biotech Res Innov."},{"key":"B103","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1747-0285.2009.00825","article-title":"Advantages of a synthetic peptide immunogen over a protein immunogen in the development of an anti-pilus vaccine for Pseudomonas aeruginosa","volume":"74","author":"Kao","year":"2009","journal-title":"Biol Drug Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nature Rev."},{"key":"B105","year":"2015","journal-title":"LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine"},{"key":"B106","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3389\/fimmu.2018.00967","article-title":"NH36 and F3 antigen-primed dendritic cells show preserved migrating capabilities and CCR7 expression and F3 is effective in immunotherapy of visceral leishmaniasis","volume":"9","author":"Nico","year":"2018","journal-title":"Front Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00813\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T01:20:50Z","timestamp":1663291250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00813\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,16]]},"references-count":106,"alternative-id":["10.3389\/fimmu.2019.00813"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00813","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,16]]},"article-number":"813"}}